Zobrazeno 1 - 10
of 29
pro vyhledávání: '"A. H. G. Paterson"'
Autor:
Patricia A. Ganz, Hanna Bandos, Charles E. Geyer, André Robidoux, Alexander H. G. Paterson, Jonathan Polikoff, Luis Baez-Diaz, Adam M. Brufsky, Louis Fehrenbacher, Ann W. Parsons, Patrick J. Ward, Louise Provencher, John T. Hamm, Philip J. Stella, Robert L. Carolla, Richard G. Margolese, Henry R. Shibata, Edith A. Perez, Norman Wolmark
Publikováno v:
Breast Cancer Res Treat
Breast cancer research and treatment, vol 192, iss 1
Breast cancer research and treatment, vol 192, iss 1
BackgroundThe NSABP B-36 compared four cycles of doxorubicin and cyclophosphamide (AC) with six cycles of 5-fluorouracil, epirubicin, and cyclophosphamide (FEC-100) in node-negative early-stage breast cancer. A sub-study within B-36, focusing on symp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2cc37978c6f5023778ffd6e619163ac4
https://europepmc.org/articles/PMC8979645/
https://europepmc.org/articles/PMC8979645/
Autor:
Charles E. Geyer, Hanna Bandos, Priya Rastogi, Samuel A. Jacobs, André Robidoux, Louis Fehrenbacher, Patrick J. Ward, Jonathan Polikoff, Adam M. Brufsky, Louise Provencher, Alexander H. G. Paterson, John T. Hamm, Robert L. Carolla, Luis Baez-Diaz, Thomas B. Julian, Sandra M. Swain, Eleftherios P. Mamounas, Norman Wolmark
Publikováno v:
Breast Cancer Research and Treatment. 193:565-565
Autor:
Robert G. Josse, Christina L. Addison, Eitan Amir, Iryna Kuchuk, A. H. G. Paterson, Kent Russell, Mark Clemons
Publikováno v:
Journal of Bone Oncology
Bone remains the most common site of breast cancer recurrence. The results of population studies, pre-clinical research and clinical studies in patients with metastatic disease provided a rationale for testing bone-targeted agents in the adjuvant set
Publikováno v:
Journal of Cancer Education. 25:493-496
Breast cancer is the most common cancer diagnosed in women. The present study evaluated the family physicians' (FPs) understanding of adjuvant hormonal therapies for an early breast cancer. FPs were invited to attend teaching workshops on this topic,
Autor:
Mothaffar F. Rimawi, Stewart J. Anderson, Eleftherios P. Mamounas, Alan S. Coates, Beat J. K. Thurlimann, Irene Wapnir, Alexander H. G. Paterson, Miguel Martin, István Láng, Shari I. Gelber, Charles E. Geyer, Norman Wolmark, Stefan Paul Aebi, J. W.R. Nortier, Priya Rastogi, Richard D. Gelber, Meredith M. Regan, José Manuel Baena Cañada, Andre Robidoux, Karen N. Price
Publikováno v:
Journal of Clinical Oncology. 35:513-513
513 Background: ILRR is associated with a high risk of developing breast cancer distant metastases and death. The CALOR trial (NCT00074152) investigated the effectiveness of CT following local therapy for ILRR. Previously reported results at 5-yrs me
Autor:
Glenwood D. Goss, Peter Anglin, Barbara Melosky, William K. Evans, Ronald Burkes, Ian Quirt, Alexander H. G. Paterson, Robert Grimshaw, Robert Turner, Félix Couture
Publikováno v:
Journal of Pain and Symptom Management. 22:954-965
Anemia is a common cause of cancer-related fatigue. A systematic review of the literature was performed to establish guidelines on the use of epoetin alfa for the treatment of anemia. The evidence in support of these guidelines was selected, reviewed
Autor:
Alexander H. G. Paterson
Publikováno v:
Cancer. 88:3038-3046
BACKGROUND. Bisphosphonates (BPs) reduce bone resorption rates by inhibiting osteoclast function, although direct antineoplastic effects and poorly understood effects on bone pain also may occur. Within the family of BPs there are more similarities i
Autor:
Alexander H G Paterson
Publikováno v:
Acta Oncologica. 44:80-82
Autor:
Lisa DiFrancesco, Alexander H. G. Paterson, Brad Thompson, Don Morris, Peter A. Forsyth, Matthew C. Coffey, Xiaolan Feng, Kevin Fonseca
Publikováno v:
Investigational new drugs. 31(3)
Purpose This open-labeled, phase I clinical trial was designed to determine the safety and tolerability of percutaneous intralesional administration of wild-type oncolytic revovirus type 3 Dearing (Reolysin®) in cancer patients with accessible and e
Autor:
D. Scott Ernst, Eduardo Bruera, Penny M. A. Brasher, R. Neil MacDonald, Alexander H. G. Paterson, John Jensen
Publikováno v:
Journal of Pain and Symptom Management. 7:4-11
After a baseline symptom and laboratory assessment, 24 patients with metastatic bone disease and pain were randomized to receive either a 4-hr intravenous infusion of 2-dichloromethylene bisphosphonate (Cl2MDP), 600 mg in 500 mL of normal saline, or